XSHG
605033
, Last price
Name
Shaanxi Meibang Pharmaceutical Group Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
0.35
Vol. 1Y
—
Shs. 5Y
6.02%
Rev. 5Y
9.91%
Div Yld LY
—
Div Yld TTM
—
Revenues
912m
+2.98%
Net income
49m
+32.03%
CFO
237m
-15.39%
Dividend
Jun 17, 20260.1 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Weinan, China, in 1998, Shaanxi Meibang Pharmaceutical Group Co., Ltd. operates within the agricultural chemicals sector. The company is dedicated to the research, development, manufacturing, and commercialization of pesticide formulations, with its product portfolio prominently featuring fungicides and insecticides.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||